Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.67
-0.28 (-2.77%)
At close: Aug 18, 2025, 2:54 PM
Anavex Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -48.17M | -47.14M | -46.49M | -43M | -41.53M | -40.59M | -43.16M | -47.5M | -51.65M | -52.74M | -50.07M | -47.98M | -45.41M | -43.22M | -40.94M | -37.91M | -32.16M | -28.46M | -27.54M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 9.84M | 8M | 9.21M | 9.44M | 10.61M | 11.99M | 13.31M | 16.37M | 19.23M | 19.35M | 19.82M | 18.38M | 15.49M | 13.79M | 11.2M | 8.23M | 5.74M | 4.7M | 4.55M |
Other Working Capital | -2.91M | 5.2M | 403K | -2.67M | 1.26M | 443.33K | 2.21M | 2.55M | 4.57M | 3.51M | 3.07M | 6.28M | 3.1M | 2.11M | 3.3M | -1.46M | -2.74M | -1.73M | -1.53M |
Other Non-Cash Items | 59K | n/a | n/a | n/a | -58.5K | 3.42M | 4.27M | 9.05M | 11.03M | 11.19M | 17.89M | 13.35M | 14.5M | 13.96M | 8.27M | 8.25M | 5.13M | 2.41M | 1.09M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.17M | 9.32M | 1.67M | 2.75M | 971.25K | -3.87M | -309.09K | 2.5M | 5.6M | 7.16M | 3.72M | 5.36M | 2.05M | 1.09M | 3.72M | -706.44K | -2.55M | -1.72M | -441.45K |
Operating Cash Flow | -37.1M | -29.81M | -35.61M | -30.81M | -30M | -32.48M | -29.31M | -27.79M | -25.98M | -25.38M | -26.53M | -24.24M | -27.87M | -28.34M | -26.01M | -30.38M | -28.96M | -25.49M | -23.43M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.93M | 4.64M | 4.64M | 4.64M | 1.31M | 868.34K | 1.05M | 1.05M | 181.18K | 509.09K | 76.29K | 303.31K | 2.53M | 135.03K | 513.89K | 23.65K | -2.58M | -539.66K | -667.22K |
Financial Cash Flow | -494K | 6.2M | 12.62M | 11.97M | 13.94M | 18.4M | 29.45M | 29.65M | 27.6M | 25.5M | 19.01M | 21.29M | 23.51M | 105.82M | 129.8M | 153.24M | 158.9M | 74.78M | 43.33M |
Net Cash Flow | -37.59M | -23.61M | -22.99M | -18.84M | -16.06M | -14.08M | 143.04K | 1.87M | 1.62M | 124.29K | -7.52M | -2.95M | -4.36M | 77.48M | 103.79M | 122.86M | 129.94M | 49.3M | 19.9M |
Free Cash Flow | -37.1M | -29.81M | -35.61M | -30.81M | -30M | -32.48M | -29.31M | -27.79M | -25.98M | -25.38M | -26.53M | -24.24M | -27.87M | -28.34M | -26.01M | -30.38M | -28.96M | -25.49M | -23.43M |